Compare Celestica Inc (CLS) vs Goldman Sachs Group Inc (GS) Price & Performance

Celestica (CLS) trades at $345.18, down 4.08% over 24 hours, with technical indicators showing a bearish trend near key support at $339. The company demonstrates strong fundamentals with Q1 2026 EPS of $2.16 beating estimates, revenue growth accelerating to 55.55% YoY, and a robust ROE of 52.45%. Recent leadership appointments and raised FY2026 revenue guidance to $19 billion reflect operational momentum amid AI and data center demand tailwinds.

Wall Street maintains a bullish outlook with 63% buy ratings and a $440.10 consensus price target, implying 27% upside. Key risks include competitive pressures in the EMS sector and execution challenges in margin expansion. The stock's high P/E of 41.82 warrants monitoring, but earnings beats and institutional confidence support a positive investment case pending Q2 results on July 28, 2026.

Goldman Sachs (GS) trades at $1,045.91, down 0.88% on the day, with a bullish technical outlook and strong earnings momentum after three consecutive quarterly beats. Revenue grew to $58.28B in 2025, with net income reaching $17.18B and a net margin of 29.89%. The company is positioned to benefit from near-record M&A activity and high-profile IPOs like Anthropic, with CEO David Solomon noting investor 'greed mode' amid robust liquidity. Analysts maintain a consensus price target of $1,080 with 40% buy ratings.

The stock offers upside to the consensus target, supported by earnings growth and investment banking tailwinds, but faces risks from volatile cash flows, high leverage, and macroeconomic sensitivity. Institutional sentiment is cautiously optimistic, though negative operating cash flow and debt levels warrant monitoring for sustained shareholder value.